Home
About Us
Our Supply
Import from India
Export Services
Global Presence
- Africa
- ASIA
- EUROPE
- LATAM
- Middle East
- NORTH AMERICA
- OCEANIA
Import Medicines Worldwide
Resources
- Blog
Contact Us

Enquire Now

Blog

Home
Blog

No blog posts yet.

The Indian Pharma is a WHO-GMP certified pharmaceutical export company from India, supplying quality-assured generic medicines and pharmaceutical products to international B2B buyers, hospitals, NGOs, government institutions and procurement organizations.

Latest Releases

Visit our Blog

Know Company

About Us

Contact Details

Phone: (+91) 8527273611
WhatsApp: (+91) 9810469557
info@theindianpharma.com
905 , I – Thum Business Park, Plot No. A-40, Unit No. 5, Tower A, Sector-62, Noida – 201301 (India)

The Indian Pharma © 2026. All Rights Reserved.

Disclaimer: TheIndianPharma.com is a B2B generic medicine exporter. All products are supplied exclusively to licensed pharmaceutical importers, distributors, and healthcare institutions. Nothing on this website constitutes medical advice. All medicines are prescription-only and subject to local regulatory approvals. The Indian Pharma (TIP) is a pharmaceutical trading entity that procures and supplies prescribed medicines strictly from manufacturers or duly authorized distributors. The company does not manufacture, formulate, or alter any pharmaceutical products. All trademarks, brand names, and product names referenced remain the property of their respective owners. Any use of such names is solely for identification purposes and is in compliance with the provisions of the Trademark Act, 1999, including principles of fair use. The Indian Pharma (TIP) Private Ltd does not claim ownership of, nor does it assert any rights over, any patents associated with the products supplied. Compliance with patent laws, including the Patents Act, 1970, rests with the respective patent holders, manufacturers, or marketing authorization holders. The company facilitates access to certain medicines, including new launches, through legally permissible channels such as named patient import, strictly against valid prescriptions and in accordance with applicable laws and regulatory requirements. Nothing herein shall be construed as an inducement or authorization to infringe any intellectual property rights.